Associated comorbidities of patients with Rheumatoid Arthritis in external consulation
Abstract
Introduction: Rheumatoid arthritis (RA), is a chronic, autoimmune, systemic inflammatory disease that affects the articular system with polyarthritis, but also affects other extra-articu- lar tissues and organs. The aim of this study was to investigate the comorbidities of patients with RA in a rheumatology practice.
Methodology: cross-sectional study in adults with a diagnosis of RA, in a rheumatology outpatient clinic. Centro Clínico Universitario de Oriente, during the period December 2011 to December 2019 in Ciudad Bolivar, Venezuela.
Results: 94 patients with RA participated, the predominant sex was female with 87.2%; the average age was 52.5±13.1 years. The time of evolution of the patients was 8.2±9.2 years, with a follow-up time in consultation of 12.2±17.3 months. Regarding the cumulative treatment received by the patients, steroids, prednisone and deflazacort, were initially used in 64.9%. In the sample studied the mean initial DAS-28 was 5.4±1.4. The most frequent co- morbidity was high blood pressure (HBP) with 27.7% and according to the Charlson index, 5.2% had heart failure.
Conclusions: Consistent with previous studies, cardiovascular morbidity was the most fre- quent in this study, taking into account that patients with variability in the time of RA evolution were included. It is important to emphasize RA as a disease of high cardiovascular risk and to redirect strategies that address this risk factor.
Downloads
References
(1) Muñetón G, Quintana G. La epidemiología de la artritis reumatoide. Rev Colomb Reumatol. 2015;3(22):145–7.
(2) Morales LA. Artritis reumatoide. Rev Med Cos Cen. 2013;70(607): 523-528.
(3) Hernández DMP, Torres CH, Morejón JAG, Armenteros RG, Pineda YR, Carta US, et al. Evaluación de la calidad de vida relacionada con la salud en pacientes con artritis reumatoide en el Centro de Reumatología. Rev cuba reumatol [Internet]. 2014;1(17):48–60.
(4) Vinaccia S, Quiceno J.M, Lozano F, Romero S. Calidad de vida relacionada con la salud, percepción de enfermedad, felicidad y emociones negativas en pacientes con diagnóstico de artritis reumatoide. Acta.colomb.psicol, 2017;1(20), 49-59.
(5) Fuentes-Silva Y. Enfermedad cardiovascular y artritis reumatoide. Complejo Universitario Hospitalario “Ruíz y Páez” 2009. [Tesis de Grado]. Esc. Cs. Salud. Dpto. de Medicina. Bolívar, Venezuela. U.D.O; 2010.
(6) Mendez-Rayo T, Ochoa-Zárate L, Posso-Osorio I, Ortiz E, Naranjo Escobar J, Tobón GJ. Interpretación de los autoanticuerpos en enfermedades reumatológicas. Rev Colomb Reumatol. 2018; 25(2):112–25.
(7) Romero M, Stajnsznajder P, Cassan A. Artritis reumatoide infor- mación actualizada para pacientes y familiares. Barcelona, España. 2010.
(8) Bande JM, Papasidero SB, Medina MA, Santa Cruz MJ, Klajn DS, Caracciolo JÁ, et al. Validación del HAQ-UP-A (Health Assessment Questionnaire-Upper limbs Argentine version) en pacientes con artritis reumatoide. Reumatol Clín (Engl Ed). 2021;1(17):20–4.
(9) Otero ZAG, Mesa JLE, Jiménez CF, Medina EAR, López JAB, Otero LHG. Caracterización clínico–epidemiológica de pacientes con artritis reumatoide. Finlay. 2015;4(5):264–74.
(10) Bellorin A-V, Valestrini Abreu EI, Noel G, Torres Delgado OD, Bracho Niño IJ, Riera H, et al. Calidad de vida en pacientes con artritis reumatoide. Avances en Biomedicina. 2018;3(7):151–8.
(11) Rojano J, Rodríguez M, Rodríguez E, González L. Percepción de los pacientes de artritis reumatoidea con relación a su enfermedad. Rev Digit Postgrado. 2020;3(9):e235.
(12) Rojas Oré, S. Artritis reumatoide y comorbilidad Hospital Nacional Edgardo Rebagliati Martins 2017-2018 [Proyecto de Investigación]. Lima: Universidad de San Martín de Porres, Facultad de Medicina Humana; 2019.
(13) Acosta Hernández RR, Castell Pérez C, Hernández Duarte MJ, Pernas González A. Comorbilidad y mortalidad en una cohorte de pacientes cubanos con artritis reumatoide. Rev Cubana Med. 2009;48(2):0–0.
(14) Organización Mundial de la Salud. Concentraciones de hemoglobina para diagnosticar la anemia y evaluar su gravedad. Organización Mundial de la Salud; 2011.
(15) Aguilar S. Manifestaciones hematológicas en pacientes con artritis reumatoide en el HOSPITAL NACIONAL “Ramiro Prialé Prialé” Huancayo – 2017. [Tesis de grado]. Escuela Profesional de Medicina Humana. Facultad de Medicina Humana. Universidad Peruana Los Andes. 2019.
(16) Padilla-Hernández RO, Simón-Campos JA. Correlación de PCR y velocidad de sedimentación globular con la actividad de la artritis reumatoide. Rev Med Inst Mex Seguro Soc. 2008;46(6):591–6.
(17) Bautista-Molano W, Fernández-Avila D, Jiménez R, Cardozo R, Marín A, Soler MDP, et al. Perfil epidemiológico de pacientes colombianos con artritis reumatoide evaluados en una clínica especializada de atención integral. Reumatol Clin. 2016;12(6): 313–8.
(18) Wassenberg S, Rau R, Steinfeld P, Zeidler H. Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebocontrolled trial. Arthritis Rheum. 2005;52(11):3371–80.
(19) 19. Svensson B, Boonen A, Albertsson K, van der Heijde D, Keller C, Hafström I. Low-dose prednisolone in addition to the initial diseasemodifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial. Arthritis Rheum. 2005;52(11):3360-70.
(20) Hafström I, Albertsson K, Boonen A, van der Heijde D, Landewé R, Svensson B, et al. Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying antirheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study. Ann Rheum Dis. 2009;68(4):508–13.
(21) Valinotti V, Román L, Paats A, Glizt R, Mallorquín A, Ávila-Pedretti G, et al. Relationship between disease duration and clinical features in patients with Rheumatoid Arthritis in two reference centers. Rev parag reumatol. 2020;6(1):11-6.
(22) Azuaga-Piñango AB, Castellanos-Moreira R, Rodriguez-Garcia SC, Mandelikova S, Frade-Sosa B, Diaz-Castillo A, et al. AB0332 Comorbidities prevalence and charlson index in a cohort of patients with rheumatoid arthritis. In: Rheumatoid arthritis – comorbidity and clinical aspects. BMJ Publishing Group Ltd and European League Against Rheumatism; 2018.
(23) Tiippana-Kinnunen T, Kautiainen H, Paimela L, Leirisalo-Repo M. Co-morbidities in Finnish patients with rheumatoid arthritis: 15-year follow-up. Scand J Rheumatol. 2013;42(6):451–6.
(24) Solis Cartas U, Haro Chávez JM, Crespo Vallejo JR, Salba Maqueira M. Absceso óseo en un paciente joven con artritis reumatoide, a propósito de un caso. Rev cuba reumatol. 2019;12(1);21.
Copyright (c) 2022 Paraguayan Journal of Rheumatology
This work is licensed under a Creative Commons Attribution 4.0 International License.
